Insulin Patch Pumps Market Report 2026

Insulin Patch Pumps Market Overview

• Insulin Patch Pumps market size has reached to $1.56 billion in 2025 • Expected to grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: Rising Diabetes Prevalence Fuels Growth Of Insulin Patch Pumps Market • Market Trend: Innovation In Insulin Patch Pumps With Advanced Infusion Set • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Insulin Patch Pumps Market?

Insulin patch pumps are small, computerized devices with pre-programmed delivery of insulin dosage to a diabetic patient to conveniently manage their blood sugar. An insulin patch pump is often attached to a strap under the garments, in a pocket, on the waist belt, and with an adhesive patch on the stomach or arm of the patient. The main types of insulin patch pumps are traditional insulin pumps, smart insulin pump and disposable insulin pumps. The traditional insulin pumps are a small device used to delivers insulin through a small plastic tube. The device continually pumps insulin throughout the day and night. Before meals, it can also supply insulin more quickly. This mode of delivery includes basal and bolus. The pumps come in two types namely tethered pump and patch pump to treat patients with type 1 diabetes and type 2 diabetes. These are mainly used in hospital, clinics, laboratories, and others.

What Is The Insulin Patch Pumps Market Growth Forecast?

The insulin patch pumps market size is expected to see rapid growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing adoption of closed-loop insulin delivery systems, rising investments in digital diabetes care, expansion of personalized insulin therapy solutions, increasing demand for remote glucose monitoring, advancements in miniaturized pump technologies. Major trends in the forecast period include increasing adoption of tubeless patch pump systems, rising demand for connected and smart insulin pumps, growing integration of continuous glucose monitoring, expansion of automated insulin delivery technologies, enhanced focus on discreet and wearable designs.

Global Insulin Patch Pumps Market Segmentation

1) By Type: Reusable Insulin Patch Pumps, Fully Disposable Insulin Patch Pumps, Smart Or Connected Insulin Patch Pumps, Automated Insulin Patch Pumps 2) By Mode: Basal, Bolus 3) By Application: Type 1 Diabetes, Type 2 Diabetes Subsegments: 1) By Reusable Insulin Patch Pumps: Reusable Controller with Disposable Patch Modules, Reusable Controller with Replaceable Insulin Reservoirs, Hybrid Reusable Patch Pump Systems 2) By Fully Disposable Insulin Patch Pumps: Pre-Filled Disposable Insulin Patch Pumps, Refillable Disposable Insulin Patch Pumps, Short-Wear Disposable Patch Pumps (24–72 hours) 3) By Smart or Connected Insulin Patch Pumps: Bluetooth-Enabled Insulin Patch Pumps, Mobile App-Integrated Patch Pumps, Cloud-Connected Insulin Patch Pumps 4) By Automated Insulin Patch Pumps: Hybrid Closed-Loop Insulin Patch Pumps, Fully Closed-Loop (Autonomous) Insulin Patch Pumps, CGM-Integrated Automated Patch Pumps

What Is The Driver Of The Insulin Patch Pumps Market?

The rising prevalence of diabetes across the globe is expected to drive the growth of the insulin patch pumps market in the forecast period. Diabetes is a major disease around the world, and it is caused by many reasons due to lifestyle and food habits. Insulin patch pumps help in the convenient delivery of insulin directly into the body, and many people with diabetes find insulin pumps to be more convenient than insulin injections. The rising prevalence of diabetes leads to a need for insulin patch pumps. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Therefore, the rising prevalence of diabetes across the globe will propel the growth of the insulin patch pumps industry.

Key Players In The Global Insulin Patch Pumps Market

Major companies operating in the insulin patch pumps market are Insulet Corporation, Medtronic PLC, Tandem Diabetes Care Inc., Ypsomed Holding AG, AMF Medical SA, Cequr SA, Debiotech SA, Bigfoot Biomedical Inc., Valeritas Inc., Cellnovo Group SA, Medella Health Ltd., ViCentra B.V., SFC Fluidics Inc., Pancreum Inc., Beta Bionics Inc., Embecta Corp., SOOIL Development Co. Ltd., EOFLOW Co. Ltd., 3S Corporation, Apex Medical Devices

Global Insulin Patch Pumps Market Trends and Insights

Major companies operating in insulin patch pumps are focusing on innovating new products, such as the Infusion Set for Insulin Pumps, to provide reliable services to customers. The Infusion Set for Insulin Pumps is used as an insulin patch pump designed for up to 7 days of wear for the subcutaneous infusion of insulin. For instance, in September 2024, Embecta, a U.S.-based diabetes care company, received FDA 510(k) clearance for its first insulin patch pump, which features a 300-unit insulin reservoir and is designed for up to 3 days of wear. This launch represents a significant innovation in insulin delivery by offering a flexible, convenient option for people with diabetes, combining patch-pump technology with a potentially reduced device burden.

What Are Latest Mergers And Acquisitions In The Insulin Patch Pumps Market?

In January 2023, Tandem Diabetes Care Inc., a US-based medical device manufacturer, acquired AMF Medical SA for an undisclosed amount. With this acquisition, Tandem Diabetes Care, Inc., aims to expand its portfolio in diabetes care and bring the benefits of advanced insulin pump therapy to people. AMF Medical SA is a Switzerland-based MedTech company that develops insulin patch pumps.

Regional Outlook

North America was the largest region in the insulin patch pumps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Insulin Patch Pumps Market?

The insulin patch pumps market consist of sales of insulin reservoir, pumping, mechanism and cannula. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.